Back
ADC Therapeutics SA Vs. NLS Pharmaceutics Industry Stock Comparison
Sell
27
ADCT
ADC Therapeutics SA
Last Price:
2.39
Seasonality Move:
199.95%
Sell
16
NLSP
NLS Pharmaceutics
Last Price:
3.07
Seasonality Move:
34.69%
Sell
27
ADC Therapeutics SA (ADCT)
is a Sell
Is ADC Therapeutics SA a Buy, Sell or Hold?
- The current ADC Therapeutics SA [ADCT] share price is $2.39. The Score for ADCT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- ADCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
16
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $3.13. The Score for NLSP is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ADCT Stock Price Chart
What is ADC Therapeutics SA's stock price today?
-
The ADC Therapeutics SA share price today is $2.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADCT is experiencing selling pressure, which indicates risk of future bearish movement.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $3.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight selling pressure.
ADCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 31.58 | Sell |
| Chaikin Money Flow: | -279394 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.8 - 3.14) | Sell |
| Bollinger Bands (100): | (2.77 - 3.41) | Sell |
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 30.48 | Sell |
| Chaikin Money Flow: | -7355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.65 - 4.77) | Sell |
| Bollinger Bands (100): | (4.47 - 7.79) | Sell |
ADCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.85 | Sell |
| 20-day SMA: | 2.94 | Sell |
| 50-day SMA: | 3.01 | Sell |
| 200-day SMA: | 3.65 | Sell |
| 8-day EMA: | 2.77 | Sell |
| 20-day EMA: | 2.9 | Sell |
| 50-day EMA: | 2.99 | Sell |
| 200-day EMA: | 3.15 | Sell |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.75 | Sell |
| 20-day SMA: | 4.02 | Sell |
| 50-day SMA: | 4.7 | Sell |
| 200-day SMA: | 7.67 | Sell |
| 8-day EMA: | 3.63 | Sell |
| 20-day EMA: | 4.01 | Sell |
| 50-day EMA: | 4.73 | Sell |
| 200-day EMA: | 9.55 | Sell |
ADC Therapeutics SA Earnings Growth & ADCT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.45 per share, and a decrease next year of $0.00 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ADC Therapeutics SA Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NLS Pharmaceutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||